Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Immunotherapy Drugs Market Worth $475+ Billion, Globally, by 2028 at 14+% CAGR | The Insight Partners

This image opens in the lightbox

News provided by

The Insight Partners

17 Oct, 2022, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, Oct. 17, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Immunotherapy Drugs Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 – COVID-19 Impact and Global Analysis – by type, clinical indication, end user, and geography" the global immunotherapy drugs market size is expected to grow from USD 186.32 billion in 2021 to USD 476.04 billion by 2028; it is expected to grow at a CAGR of 14.4% from 2022 to 2028.

Download Sample PDF Brochure of Immunotherapy Drugs Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00003416/

Global Immunotherapy Drugs Market Report Scope, Segmentations, Regional & Country Scope:

Report Coverage

Details

Market Size Value in

USD 186.32 Billion in 2021

Market Size Value by

USD 476.04 Billion by 2028

Growth rate

CAGR of 14.4% from 2022 to 2028.

Forecast Period

2022-2028

Base Year

2021

No. of Pages

150

Historical data available

Yes

Segments covered

Type, Clinical Indication, and End User

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Companies Covered

Incyte Corporation, Juno Therapeutics, Celldex Therapeutics, Tesaro, Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Novartis AG, BioNTech SE, Sanofi, GlaxoSmithKline Plc, Pfizer Inc., Merck & Co, Johnson & Johnson

Key Research Capabilities

Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development

Global Immunotherapy Drugs Market Forecast to 2028 - Latest COVID-19 Analysis

https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00003416/

Browse key market insights spread across 150 pages with list of tables & list of figures from the report, "Immunotherapy Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis - By Type (Vaccine Adjuvants, Dendritic Cell Activators & Growth Factors, T-Cell Stimulators & Growth Factors, Immune Checkpoint Inhibitors, Monoclonal Antibodies, Interleukins & Interferons, and Others), Clinical Indication (Cancer, Inflammatory Diseases, Autoimmune Diseases, Infectious Diseases, and Others), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others)" in detail along with the table of contents: https://www.theinsightpartners.com/reports/immunotherapy-drugs-market

Incyte Corporation; Pfizer Inc.; Juno Therapeutics; Novartis AG; Celldex Therapeutics; Tesaro, Inc; Amgen Inc; F. Hoffmann-La Roche Ltd; and Merck&Co. are a few of the key players profiled during the study of the global immunotherapy drugs market. Several other major companies were analyzed during this study to get a holistic view of the immunotherapy drugs market and its ecosystem.

Based on type, the global immunotherapy drugs market is segmented into vaccine adjuvants, dendritic cell activators & growth factors, T-cell stimulators & growth factors, immune checkpoint inhibitors, monoclonal antibodies, interleukins & interferons, and others. The monoclonal antibodies segment accounted for the largest market share in 2021, and it is expected to dominate the global immunotherapy drugs market over the forecast period. Moreover, for cancer treatment, only two monoclonal immunotherapy drugs have been approved, i.e., bevacizumab (Avastin) and ramucirumab (Cyramza). These drugs block blood vessels that supply nutrients to cancerous tumors. Further, other drugs are undergoing investigation in clinical trials across various countries.  Medications that are studied in clinical trials include T-cell therapy, monoclonal antibodies (including immune checkpoint inhibitors), and oncolytic virus therapies. Immunomodulator medications targeting CTLA-4 inhibitors currently being studied for the treatment of lung cancers include tremelimumab and iplimumab.

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00003416/

According to the National Cancer Institute, there were 1,806,590 new cancer cases in the US, and 606,520 associated deaths (mortalities) were registered in 2020. Moreover, according to the National Cancer Institute, the number of cancer survivors is expected to increase from 16.9 million in January 2019 to 22.2 million by 2030. As a result, manufacturers are inclined toward inventing novel approaches and methods that might curb the growth of cancer. Hence, cancer immunotherapy drugs, combined with radiation and chemotherapy treatments, prove to be an effective alternative to combat cancer. For instance, in January 2022, the US Food and Drug Administration (FDA) approved tebentafusp-tebn (KIMMTRAK), the bispecific fusion protein, for the treatment of HLA-A02:01-positive adult patients with unresectable uveal melanoma.

Based on clinical indications, the global immunotherapy drugs market is segmented into cancer, inflammatory diseases, autoimmune diseases, infectious diseases, and others. The cancer segment accounted for the largest market share in 2021, and it is expected to retain its dominance during the forecast period. In February 2022, the FDA approved the FoundationOne CDx, the companion diagnostic test, to identify patients with microsatellite instability high (MSI-H) solid tumors who may be candidates for immunotherapy. Moreover, the infectious diseases segment is expected to witness the highest CAGR from 2022 to 2028.

Based on end user, the global immunotherapy drugs market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment accounted for the largest market share in 2021, and it is expected to continue its dominance in the global immunotherapy drugs market over the forecast period. A rise in spending on immunotherapies by hospitals and high demand for advanced therapies that are only provided by hospitals & clinics are expected to support the growth of the immunotherapy drugs market.

Quickly Purchase Premium Copy of Immunotherapy Drugs Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00003416/

Go through further research published by The Insight Partners:

ISDN Modem Market - The global ISDN modem market size was valued US$ 982.97 thousand in 2022, it is estimated to register a CAGR of -80.6% from 2022 to 2024.

Semiconductor Bonding Market - The global semiconductor bonding market size was valued US$ 669.48 million in 2022, it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.

Recycled Ocean Plastics Market - The global recycled ocean plastics market size was valued at US$ 14,432.91 million in 2022, it is expected to grow at a CAGR of 8.5% from 2022 to 2028.

Femtech Market – The global femtech market size is expected to grow from US$ 11.63 billion in 2021 to US$ 22.29 billion by 2028, with an estimated CAGR of 9.9% from 2022 to 2028.

Women Healthcare Market – The global women healthcare market size was valued at US$ 30.5 billion in 2021 and is likely to reach US$ 42.8 billion by 2028; it is expected to grow at a CAGR of 4.8% between 2022 and 2028.

Orthopedic Implants Market – The global orthopedic implants market size is expected to grow from US$ 46,101.2 million in 2021 to US$ 67,235.1 million by 2028; it is expected to grow at a CAGR of 5.6% from 2022 to 2028.

Surgical Lasers Market – The global surgical lasers market size is expected to grow from US$ 3,625.96 million in 2021 to US$ 6,031.09 million in 2028, with an estimated CAGR of 7.7% from 2022 to 2028.

Immunotherapy Drugs Market – The global immunotherapy drugs market size is expected to grow from US$ 186.32 billion in 2021 to US$ 476.04 billion by 2028; it is expected to grow at a CAGR of 14.4% from 2022 to 2028.

Enteral Feeding Formulas Market – The global enteral feeding formulas market size is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2028 at a CAGR of 6.0% between 2022 and 2028.

Fetal Monitoring Market – The global fetal monitoring market size was valued at US$ 3,870.9 million in 2021 and is likely to reach a value of US$ 6,438.2 million by 2028 at a CAGR of 7.6% between 2022 and 2028.

Cell Culture Market – The global cell culture market size was valued at US$ 21,722.8 million in 2021 and is likely to reach US$ 44,330.1 million by 2028; it is expected to grow at a CAGR of 10.7% between 2022 and 2028.

Stroke Management Market – The global stroke management market size is expected to grow from US$ 33.48 billion in 2021 to US$ 55.37 billion by 2028; it is expected to grow at a CAGR of 7.5% from 2022 to 2028.

Diabetic Retinopathy Market – The global diabetic retinopathy market size is expected to grow from US$ 7.78 billion in 2021 to US$ 12.04 billion by 2028; it is expected to grow at a CAGR of 6.5% from 2022 to 2028.

Endotherapy Devices Market – The global endotherapy devices market size was valued at US$ 4,218.9 million in 2021 and is likely to reach US$ 6,494.4 million by 2028; it is expected to grow at a CAGR of 6.4% between 2022 and 2028.

Small Satellite Market – The global small satellite market size is expected to grow from US$ 5.8 Bn in 2021 to US$ 22.9 Bn by 2028 at a CAGR of 22.2% between 2022 and 2028.

Microgrid Market – The global microgrid market size is expected to grow from US$ 25 billion in 2021 to US$ 60 billion by 2028; it is estimated to grow at a CAGR of 17.0% during 2022–2028.

UV Disinfection Equipment Market – The global UV disinfection equipment market size is expected to grow from US$ 4.5 billion in 2021 to US$ 9.5 billion by 2028; it is expected to grow at a CAGR of 12.0% from 2022 to 2028.

Aircraft Electrification Market – The global aircraft electrification market size is expected to grow from US$ 1,977.47 million in 2021 to US$ 14,683.71 million by 2028; it is estimated to grow at a CAGR of 34.1% between 2022 and 2028.

Military Drone Market – The global military drone market size is expected to grow from US$ 11.70 billion in 2021 to US$ 31.38 billion by 2028 at a CAGR of 15.7% between 2022 and 2028.

Human Augmentation Market – The global human augmentation market size is expected to grow from US$ 116.88 Billion in 2021 to US$ 498.70 Billion by 2028 at a CAGR of 23.0% from 2022 to 2028.

Military Unmanned Surface Vehicle Market – The global military unmanned surface vehicle market size is expected to grow from US$ 1,512.32 million in 2021 to US$ 3,166.61 million by 2028 at a CAGR of 11.6% between 2022 to 2028.

Low GWP Refrigerants Market – The global Low GWP refrigerants market size is expected to grow from US$ 22.99 billion in 2021 to US$ 49.89 billion by 2028 at a CAGR of 11.7% between 2022 and 2028.

Food Testing Kits Market – The global food testing kits market size is expected to grow from US$ 20.73 billion in 2021 to US$ 34.14 billion by 2028 at a CAGR of 7.4% between 2022 and 2028.

Shelf-Life Testing Market – The global shelf-life testing market size is expected to grow from US$ 4.49 billion in 2021 to US$ 8.50 billion by 2028; it is estimated to grow at a CAGR of 8.9% between 2022 and 2028.

Acidity Regulators Market – The global acidity regulators market size accounted for approximately US$ 7 Bn in 2021 and is projected to exceed US$ 12 Bn by 2028 at a CAGR of 7.2% between 2022 and 2028.

3D Printing Metal Market – The global 3D printing metal market size is expected to grow from US$ 4.5 billion in 2021 to more than US$ 13 billion by 2028 at a CAGR of 16.5% between 2022 and 2028.

Building Automation System Market – The global building automation system (BAS) market size is expected to grow from US$ 70 billion in 2021 to US$ 175 billion by 2028 at a CAGR of 12% between 2022 and 2028.

Cocoa Derivatives Market – The global cocoa derivatives market size accounted for approximately US$ 26.00 billion in 2021 and is projected to exceed US$ 37.00 billion by 2028 with an estimated CAGR of 5.2% between 2022 and 2028.

Unmanned Helicopter Market – The global unmanned helicopter market size is expected to grow from US$ 3,095.76 Mn in 2021 to US$ 13,958.28 Mn by 2028 at a CAGR of 24.7% between 2022 and 2028.

Graph Database Market – The global graph database market size is expected to grow from US$ 1,854.0 million in 2021 to US$ 7,225.9 million by 2028; it is estimated to grow at a CAGR of 22.1% between 2022 and 2028.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/immunotherapy-drugs-market
Industry Research: https://www.einpresswire.com/newsroom/the_insight_partners/ | https://www.whatech.com/og/markets-research/companies/the-insight-partners-2019-05-20

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg

Modal title

Also from this source

eSIM Market Size is Set to Achieve USD 17.98 Billion by 2031, With CAGR of 18.7% | The Insight Partners

eSIM Market Size is Set to Achieve USD 17.98 Billion by 2031, With CAGR of 18.7% | The Insight Partners

According to a new comprehensive report from The Insight Partners, the global eSIM market is observing significant growth owing to the rising...

HR Analytics Market Size to Surpass USD 9.89 Billion CAGR of 14.9% during 2025-2031

HR Analytics Market Size to Surpass USD 9.89 Billion CAGR of 14.9% during 2025-2031

According to a new comprehensive report from The Insight Partners, the global HR analytics market is observing significant growth owing to the...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.